TNF and Crohn disease: Bertani et al. studied a mixed cohort of patients aged over 60 years with UC or Crohn's disease who were treated with either infliximab or vedolizumab, whereas we examined adults over 17 years with Crohn's disease and treated with an anti‐TNF drug only.